Feasibility and effectiveness of inhaled carboplatin in NSCLC patients-Reference-Cited by-同舟云学术

Feasibility and effectiveness of inhaled carboplatin in NSCLC patients

Published:2011-07-08 Issue:4 Volume:30 Page:1628-1640
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Zarogoulidis Paul,Eleftheriadou Ellada,Sapardanis Iordanis,Zarogoulidou Vasiliki,Lithoxopoulou Helliel,Kontakiotis Theodoros,Karamanos Nikolaos,Zachariadis George,Mabroudi Maria,Zisimopoulos Athanasios,Zarogoulidis Kostantinos

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-011-9714-5.pdf

Reference83 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi: 10.3322/caac.20107

2. Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122(3):1037–1057. doi: 10.1378/chest.122.3.1037

3. Stewart LA, Pignon JP (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 311:899–909

4. Spiro SG, Rudd RM, Souhami RL, Brown J, Fairlamb DJ, Gower NH, Maslove L, Milroy R, Napp V, Parmar MK, Peake MD, Stephens RJ, Thorpe H, Waller DA, West P, Big Lung Trial Participants (2004) Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax 59(10):828–836. doi: 10.1136/thx.2003.020164

5. Albain KS, Crowley JJ, LeBlanc M, Livingston RB (1991) Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 9(9):1618–1626

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09

2. A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review);International Journal of Oncology;2024-02-21

3. Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From In vitro to In vivo;Journal of Cancer;2024

4. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer;Pharmaceutics;2023-12-14

5. Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches;International Journal of Nanomedicine;2023-12